Literature DB >> 26203642

Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.

Steven J Katz1, Allison W Kurian2, Monica Morrow3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26203642     DOI： 10.1001/jama.2015.8088

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.

Authors:  Allison W Kurian; Kevin C Ward; Nadia Howlader; Dennis Deapen; Ann S Hamilton; Angela Mariotto; Daniel Miller; Lynne S Penberthy; Steven J Katz
Journal:  J Clin Oncol       Date:  2019-04-09       Impact factor: 44.544

2.  The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.

Authors:  A E Bunnell; C A Garby; E J Pearson; S A Walker; L E Panos; Joanne L Blum
Journal:  J Genet Couns       Date:  2016-06-09       Impact factor: 2.537

3.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

4.  Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Patricia A Deverka; John B Watkins; Kathryn A Phillips
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

5.  When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.

Authors:  B Meiser; V F Quinn; M Gleeson; J Kirk; K M Tucker; B Rahman; C Saunders; K J Watts; M Peate; E Geelhoed; K Barlow-Stewart; M Field; M Harris; Y C Antill; G Mitchell
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

6.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.

Authors:  Melissa K Frey; Ryan M Kahn; Eloise Chapman-Davis; Francesca Tubito; Maira Pires; Paul Christos; Samantha Anderson; Semanti Mukherjee; Bailey Jordan; Stephanie V Blank; Thomas A Caputo; Ravi N Sharaf; Kenneth Offit; Kevin Holcomb; Steven Lipkin
Journal:  J Clin Oncol       Date:  2020-01-10       Impact factor: 44.544

7.  Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.

Authors:  Allison W Kurian; Kevin C Ward; Ann S Hamilton; Dennis M Deapen; Paul Abrahamse; Irina Bondarenko; Yun Li; Sarah T Hawley; Monica Morrow; Reshma Jagsi; Steven J Katz
Journal:  JAMA Oncol       Date:  2018-08-01       Impact factor: 31.777

8.  Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.

Authors:  Steven J Katz; Irina Bondarenko; Kevin C Ward; Ann S Hamilton; Monica Morrow; Allison W Kurian; Timothy P Hofer
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

9.  Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases.

Authors:  Karin Kast; Julia Häfner; Evelin Schröck; Arne Jahn; Carmen Werner; Cornelia Meisel; Pauline Wimberger
Journal:  Breast Care (Basel)       Date:  2021-06-17       Impact factor: 2.268

10.  Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.

Authors:  Allison W Kurian; Kevin C Ward; Paul Abrahamse; Irina Bondarenko; Ann S Hamilton; Dennis Deapen; Monica Morrow; Jonathan S Berek; Timothy P Hofer; Steven J Katz
Journal:  J Clin Oncol       Date:  2021-02-09       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.